SENNA LAX- sennosides 8.6mg tablet 
TopCo Associates, LLC

----------

371 - Senna Lax

Active ingredient(s)

Sennosides 8.6mg

Purpose

Laxative

Use(s)

Warnings

Do not use

laxative products for longer than one week unless directed by a doctor

Ask a doctor before use if

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks 

Stop Use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative.

These could be signs of a serious condition.

Pregnancy/Breastfeeding

 ask a health professional before use

Keep out of reach of children

In case of accidental overdose, contact a doctor or Poison Control Center (1-800-222-1222) right away.

Directions

agestarting Dosagemaximum Dosage
adults and children 12 years of age and over2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years½ tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a doctor

Other information

Storage

Inactive ingredients

croscarmellose sodium, dibasic calcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide

Principal Display Panel

Senna Lax

Senna Lax


SENNA LAX 
sennosides 8.6mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:76162-005
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize8mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:76162-005-98200 in 1 BOTTLE; Type 0: Not a Combination Product07/01/2014
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00707/01/2014
Labeler - TopCo Associates, LLC (006935977)

Revised: 4/2021
Document Id: 422029e7-9273-4087-887e-df2aff2ad676
Set id: 83aeb90a-ab00-4e26-aa44-5259dce59018
Version: 4
Effective Time: 20210428
 
TopCo Associates, LLC